Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds

Human Gene Therapy

Volumn 16, Issue 5, 2005, Pages 609-617

  Huang, Yen Chen ^a   Riddle, Kathryn ^a   Rice, Kevin G ^b   Mooney, David J ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PLASMID DNA; POLYETHYLENEIMINE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABLE IMPLANT; BOLUS INJECTION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; QUANTITATIVE ANALYSIS; RAT; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING;

ANIMALS; BETA-GALACTOSIDASE; DNA; FEASIBILITY STUDIES; FREEZE DRYING; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; KINETICS; LACTIC ACID; MALE; PLASMIDS; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYMERS; POROSITY; RATS; RATS, INBRED LEW; TISSUE ENGINEERING; TRANSFECTION;

EID: 17644377327     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.609     Document Type: Article

References (54)

1. ALILA, H., COLEMAN, M., NITTA, H., FRENCH, M., ANWER, K., LIU, Q., MEYER, T., WANG, J., MUMPER, R., OUBARI, D., LONG, S., NORDSTROM, J., and ROLLAND, A. (1997). Expression of biologically active human insulin-like growth factor-I following intramuscular injection of a formulated plasmid in rats. Hum. Gene Ther. 8, 1785-1795.
2. BARRY, M.A., DOWER, W.J., and JOHNSTON, S.A. (1996). Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med. 2, 299-305.
3. BLESSING, T., KURSA, M., HOLZHAUSER, R., KIRCHEIS, R., and WAGNER, E. (2001). Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12, 529-537.
4. BOLETTA, A., BENIGNI, A., LUTZ, J., REMUZZI, G., SORIA, M.R., and MONACO, L. (1997). Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8, 1243-1251.
5. BONADIO, J. (2000). Tissue engineering via local gene delivery. J. Mol. Med. 78, 303-311.
6. BONADIO, J., GOLDSTEIN, S.A., and LEVY, R.J. (1998). Gene therapy for tissue repair and regeneration. Adv. Drug Deliv. Rev. 33, 53-69.
7. BONADIO, J., SMILEY, E., PATIL, P., and GOLDSTEIN, S. (1999). Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753-759.
8. BOUSSIF, O., LEZOUALC'H, F., ZANTA, M.A., MERGNY, M.D., SCHERMAN, D., DEMENEIX, B., and BEHR, J.P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92, 7297-7301.
9. BOUSSIF, O., ZANTA, M.A., and BEHR, J.P. (1996). Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3, 1074-1080.
10. BURG, K.J., PORTER, S., and KELLAM. J.F. (2000). Biomaterial developments for bone tissue engineering. Biomaterials 21, 2347-2359.
11. CHAIGNAUD, B.E., LANGER, R.S., and VACANTI, J.P. (1997). The history of tissue engineering using synthetic biodegradable polymer scaffolds and cells. In Synthetic Biodegradable Polymer Scaffolds. A. Atala and D. Mooney, eds. (Birkhauser, Boston) pp. 1-14.
12. COHEN, H., LEVY, R.J., GAO, J., FISHBEIN, I., KOUSAEV, V., SOSNOWSKI, S., SLOMKOWSKI, S., and COLOMB, G. (2000). Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7, 1896-1905.
13. FANG, J., ZHU, Y.Y., SMILEY, E., BONADIO, J., ROULEAU, J.P., GOLDSTEIN, S.A., MCCAULEY, L.K., DAVIDSON, B.L., and ROESSLER, B.J. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U.S.A. 93, 5753-5758.
14. FOMINAYA, J., and WELS, W. (1996). Target cell-specific DNA transfer mediated by a chimeric multidomain protein: Novel non-viral gene delivery system. J. Biol. Chem. 271, 10560-10568.
15. GAUTAM, A., DENSMORE, C.L., GOLUNSKI, E., XU, B., and WALDREP, J.C. (2001). Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes. Mol. Ther. 3, 551-556.
16. GOLDSTEIN, S.A., and BONADIO, J. (1998). Potential role for direct gene transfer in the enhancement of fracture healing. Clin. Orthop. 355(Suppl.), S154-S162.
17. HAAR, M.E., SHEA, L.D., HARRIS, L.D., FRANCESCHI, R.T., and MOONEY, D.J. (1998). Fabrication of bioabsorbable scaffolds for guided tissue regeneration. J. Dent. Res. 77, 1570.
18. HAFENRICHTER, D.G., PONDER, K.P., RETTINGER, S.D., KENNEDY, S.C., and FLYE, M.W. (1994a). Optimization of liver-directed retroviral gene delivery. Transplant. Proc. 26, 3379-3380.
19. HAFENRICHTER, D.G., WU, X., RETTINGER, S.D., KENNEDY, S.C., FLYE, M.W., and PONDER, K.P. (1994b). Quantitative eval uation of liver-specific promoters from retroviral vectors after in vivo transaction of hepatocytes. Blood 84, 3394-3404.
20. KARA, T., TAN, Y., and HUANG, L. (1997). In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel non-viral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 14547-14552.
21. HARRIS, L.D., KIM, B.S., and MOONEY, D.J. (1998). Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42, 396-402.
22. HIDAKA, C., IBARRA, C., HANNAFIN, J.A., TORZILLI, P.A., QUITORIANO, M., JEN, S.S., WARREN, R.F., and CRYSTAL, R.G. (2002). Formation of vascularized meniscal tissue by combining gene therapy with tissue engineering. Tissue Eng. 8, 93-105.
23. HUANG, Y.C., CONNELL, M., PARK, Y., MOONEY, D.J., and RICE, K.G. (2003). Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J. Biomed. Mater. Res. 67A, 1384-1392.
24. HUARD, J., LI, Y., PENG, H., and FU, F.H. (2003). Gene therapy and tissue engineering for sports medicine. J. Gene Med. 5, 93-108.
25. JONG, Y.S., JACOB, J.S., YIP, K.P., GARDNER, G., SEITELMAN, E., WHITNEY, M., MONTGOMERY, S., and MATHIOWITZ, E. (1997). Controlled release of plasmid DNA. J. Control. Release 47, 123-134.
26. KAY, M.A., GRAHAM, F., LELAND, F., and WOO, S.L. (1995). Therapeutic serum concentrations of human α-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819.
27. KAY, M.A., LIU, D., and HOOGERBRUGGE, P.M. (1997). Gene therapy. Proc. Natl. Acad. Sci. U.S.A. 94, 12744-12746.
28. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., MCQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTZMAN, G.J., and BYRNE, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
29. KIM, B.S., and MOONEY, D.J. (1998a). Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 16, 224-230.
30. KIM, B.S., and MOONEY, D.J. (1998b). Engineering smooth muscle tissue with a predefined structure. J. Biomed. Mater. Res. 41, 322-332.
31. KIM, J.S., KIM, B.I., MARUYAMA, A., AKAIKE, T., and KIM, S.W. (1998). A new non-viral DNA delivery vector: The terplex system. J. Control. Release 53, 175-182.
32. KIM, W.S., VACANTI, J.P., CIMA, L., MOONEY, D., UPTON, J., PUELACHER, W.C., and VACANTI, C.A. (1994). Cartilage engineered in predetermined shapes employing cell transplantation on synthetic biodegradable polymers. Plast. Reconstr. Surg. 94, 233-237; discussion, 238-240.
33. KIRCHEIS, R., KICHLER, A., WALLNER, G., KURSA, M., ORGIS, M., FELZMANN, T., BUCHBERGER, M., and WAGNER, E. (1997). Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4, 409-418.
34. LEDLEY, F.D., GRENETT, H.E., BARTOS, D.P., and WOO, S.L. (1987). Retroviral mediated transfer and expression of human α-antitrypsin in cultured cells. Gene 61, 113-118.
35. LEE, C.W., MARTINEK, V., USAS, A., MUSGRAVE, D., PICKVANCE, E.A., ROBBINS, P., MORELAND, M.S., FU, F.H., and HUARD, J. (2002). Muscle-based gene therapy and tissue engineering for treatment of growth plate injuries. J. Pediatr. Orthop. 22, 565-572.
36. LEE, H., JEONG, J.H., and PARK, T.G. (2001). A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide. J. Control. Release 76, 183-192.
37. LEE, R.J., and HUANG, L. (1996). Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271, 8481-8487.
38. LEMKINE, G.F., and DEMENEIX, B.A. (2001). Polyethylenimines for in vivo gene delivery. Curr. Opin. Mol. Ther. 3, 178-182.
39. LI, S., and HUANG, L. (2000). Nonviral gene therapy: Promises and challenges. Gene Ther. 7, 31-34.
40. MAHATO, R.I. (1999). Non-viral peptide-based approaches to gene delivery. J. Drug Target. 7, 249-268.
41. MOONEY, D.J., SANO, K., KAUFMANN, P.M., MAJAHOD, K., SCHLOO, B., VACANTI, J.P., and LANGER, R. (1997). Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37, 413-420.
42. MURPHY, W.L., and MOONEY, D.J. (1999). Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J. Periodontal Res. 34, 413-419.
43. NABEL, G.J. (1999). Development of optimized vectors for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 96, 324-326.
44. O'NEILL, M.M., KENNEDY, C.A., BARTON, R.W., and TATAKE, R.J. (2001). Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to poly-ethylenimine. Gene Ther. 8, 362-368.
45. SHEA, L.D., SMILEY, E., BONADIO, J., and MOONEY, D.J. (1999). DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17, 551-554.
46. THOMSON. R.C., MIKOS, A.G., BEAHM, E., LEMON, J.C., SATTERFIELD, W.C., AUFDEMORTE, T.B., and MILLER, M.J. (1999). Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials 20, 2007-2018.
47. VUNJAK-NOVAKOVIC, G., OBRADOVIC, B., MARTIN, T., BURSAC, P.M., LANGER, R., and FREED, L.E. (1998). Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol. Prog. 14, 193-202.
48. WEIDNER, J. (2002). Drug delivery: Maximizing efficiency of non-viral gene delivery vehicles. Drug Discov. Today 7, 532.
49. WINN, S.R., HU, Y., SFEIR, C., and HOLLINGER, J.O. (2000). Gene therapy approaches for modulating bone regeneration. Adv. Drug Deliv. Rev. 42, 121-138.
50. WOLFF, J.A., and HERWEIJER, H. (2003). Nonviral vectors for cardiovascular gene delivery. Ernst Schering Res. Found. Workshop 43, 41-59.
51. WONG, W.H., and MOONEY, D. (1997). Synthesis and properties of biodegradable polymers used as synthetic matrices for tissue engineering. In Synthetic Biodegradable Polymer Scaffolds. A. Atala and D. Mooney, eds. (Birkhauser. Boston) pp. 51-82.
52. WU, D., RAZZANO, P., and GRANDE, D.A. (2003). Gene therapy and tissue engineering in repair of the musculoskeletal system. J. Cell. Biochem. 88, 467-481.
53. YIN, W., SMILEY, E., GERMILLER, J., MECHAM, R.P., FLORER, J.B., WENSTRUP, R.J., and BONADIO, J. (1995). Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J. Biol. Chem. 270, 10147-10160.
54. ZHOU, X.H., KLIBANOV, A.L., and HUANG, L. (1991). Lipophilic polylysines mediate efficient DNA transfection in mammalian cells. Biochim. Biophys. Acta 1065, 8-14.